Economic Evaluation in Genomic and Precision Medicine: Translational and Applied Genomics
Christina Mitropoulou, Sarah Wordsworth, James Buchanan, George P. Patrinosen Limba Engleză Paperback – 23 apr 2023
- Introduces clinicians, researchers and students to essential concepts, protocols and applications of economic evaluation in genomic and precision medicine
- Demonstrates, through foundational chapters and discipline-specific case studies, how to assess the relative costs and outcomes of different genomic care pathways and implement cost-effective budgets
- Establishes clear precedents on how genomic technologies can be leveraged to simultaneously reduce costs and enhance the value of healthcare
- Features contributions from leading international medical geneticists and health economists that are actively evolved in economic assessments of genomic and precision medicine
Preț: 570.28 lei
Preț vechi: 748.11 lei
-24% Nou
Puncte Express: 855
Preț estimativ în valută:
109.18€ • 113.48$ • 90.52£
109.18€ • 113.48$ • 90.52£
Carte tipărită la comandă
Livrare economică 30 ianuarie-13 februarie 25
Livrare express 01-07 ianuarie 25 pentru 70.58 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128133828
ISBN-10: 0128133821
Pagini: 170
Dimensiuni: 191 x 235 x 11 mm
Greutate: 0.36 kg
Editura: ELSEVIER SCIENCE
Seria Translational and Applied Genomics
ISBN-10: 0128133821
Pagini: 170
Dimensiuni: 191 x 235 x 11 mm
Greutate: 0.36 kg
Editura: ELSEVIER SCIENCE
Seria Translational and Applied Genomics
Public țintă
bioscientists; human geneticists; biotech industry professionals; undergraduate and graduate students in health economics and health sciences, namely medicine, pharmacy, genetics; clinicians and health managers; public health officers, health policy makers; governmental organizations; health care professionals; hospital managersCuprins
1. Introduction to economic evaluation in health sciences
2. Foundations of pharmacogenomics and personalized medicine
3. Economic evaluation of genome-guided treatment in oncology
4. Economic evaluation of rare diseases and the diagnostic odyssey
5. Economic analysis of pharmacogenetic testing for HLA-based adverse drug reactions
6. Economic evaluation of personalized medicine interventions in medium- and low-income countries with poor proliferation of genomics and genetic testing
7. Theoretical models for economic evaluation in genomic and personalized medicine
8. Using big data in economic evaluations in genomics: Challenges and opportunities
9. Assessing the stakeholder environment and views towards implementation of personalized medicine in a healthcare setting
10. Feasibility for pricing, budget allocation, and reimbursement of personalized medicine interventions
2. Foundations of pharmacogenomics and personalized medicine
3. Economic evaluation of genome-guided treatment in oncology
4. Economic evaluation of rare diseases and the diagnostic odyssey
5. Economic analysis of pharmacogenetic testing for HLA-based adverse drug reactions
6. Economic evaluation of personalized medicine interventions in medium- and low-income countries with poor proliferation of genomics and genetic testing
7. Theoretical models for economic evaluation in genomic and personalized medicine
8. Using big data in economic evaluations in genomics: Challenges and opportunities
9. Assessing the stakeholder environment and views towards implementation of personalized medicine in a healthcare setting
10. Feasibility for pricing, budget allocation, and reimbursement of personalized medicine interventions